Insights

Security is a problem, right? Well there's a radically different way to view it – as a positive force capable of putting clear water between you and your competitors. 

The medical implant industry is set to grow from $5bn in 2017 to $16.3bn by 2022. But there are tensions to understand and hurdles to overcome for innovators intent on taking advantage.

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Products are incorporating increasingly complex technology, putting greater pressure on the supply chain. As a result, gaps are forming and the risk to reputations and revenues is growing through issues such as...

Is now the time for AI and digital tech to revolutionise the whole field of pathology? Andrew Goulter, VP, Life Sciences at Cambridge Consultants certainly thinks so, as he explains here. 

The future of industrial design and technology is in good young hands. That’s my overwhelming reaction after welcoming the winner and runners-up of a major student award we sponsored to honour excellence in breakthrough design. 

Luis Diaz-Santana, Head of Ophthalmology at Cambridge Consultants, presented at OIS European Showcase virtual conference. Watch his presentation to hear his thoughts on if Europe really is an innovation powerhouse in ophthalmology.

There is no doubt that I’ve had a busy few months as head of our medtech division for the Asia Pacific region. As judge for the new MedTech Innovator APAC scheme, I’ve been on the hunt for the best and brightest medical technology start-ups in the region. This process has given me a remarkable insight into the challenges facing the region’s growing healthcare field...
 

Regulatory approval for ophthalmic combination products is like gold dust. The final instalment in our ophthalmology series walks you through the challenges and helps plot a route to market.

Winning a prestigious international design award for our product innovation here at Cambridge Consultants is obviously fantastic – so scooping not just one but four gongs in the coveted iF Design Awards is great for everyone involved. Andy Pigeon, our head of User centred Design reviews the four winners.

The number of effective cell and gene therapies is growing rapidly, especially for treating ocular diseases. However, much less attention has been focused on the critical issue of delivery to the eye. 

If you’re a surgical robotics start-up, the timing of your risk assessment will determine the level of success you achieve. Andrew Savarese, VP, Surgical Robotics & Advanced Surgical Systems, delves into his deep experience and comes up with crucial advice to make sure you spend the right money once, not the wrong money twice.